ELIZABETH BLAIR: Open Payments
NPI 1447808498 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,147 in 61 payments from 20 companies in 2025. Trend: 2023 $403 · 2024 $987 · 2025 $1,147
Food & beverage: $1,048Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $182 |
| Astellas Pharma US Inc | 4 | $162 |
| AstraZeneca Pharmaceuticals LP | 7 | $127 |
| Novo Nordisk Inc | 6 | $112 |
| GlaxoSmithKline, LLC. | 5 | $106 |
| Corcept Therapeutics | 4 | $83 |
| Amgen Inc. | 5 | $72 |
| PFIZER INC. | 2 | $48 |
| Lundbeck LLC | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
Products named: Korlym, BREZTRI, TRELEGY ELLIPTA, VRAYLAR, Veozah, Ozempic, QULIPTA, UBRELVY.
Industry payments across TX — which companies pay providers there.
